Renaissance Capital logo

CTLT News

Drug making goes Dutch: Pharma outsourcer Patheon files for an IPO that could raise $700 million

Patheon, which provides outsourced contract drug manufacturing and development services, filed on Monday with the SEC to raise up to $100 million in an initial public offering. However, the deal size is likely a placeholder for an IPO that we estimate could...read more

Renaissance Capital's 3Q 2014 US IPO Market Review

3Q 2014 IPO Market All About BABA and Biotechs The US IPO market raised $37 billion in the third quarter, more proceeds than any quarter since the 4Q99. Most of that capital went to China's e-commerce titan Alibaba (NYSE: BABA), whose record-breaking...read more

US IPO Pricing Recap: 15 IPOs in the most active week since 2007; 66% ended at or below IPO price

15 companies had initial public offerings and raised $6.4 billion this week, making it the most active week in the IPO market since 2007. Including deals that priced yesterday and began trading today, July saw 34 IPOs, a post-tech bubble record....read more

IPO market brought down by biotech wreck and market sell off

Last night 12 IPOs were expected to price, but only 8 did.  Two deals were postponed: extended release biotech Mapi-Pharma (MAPI) and cardiovascular diagnostic firm Lantheus (LNTH).  Two deals were delayed a day: osteoporosis patch biotech Zosano...read more